1. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment
    Chunxia Ren et al, 2013, European Journal of Cancer CrossRef
  2. Concise Review: The Obesity Cancer Paradigm: Exploration of the Interactions and Crosstalk with Adipose Stem Cells
    Amy L. Strong et al, 2015, Stem Cells CrossRef
  3. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer
    Rui-Fen Wang et al, 2013, Experimental and Molecular Pathology CrossRef
  4. Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment
    Harold Ting et al, 2016, CARCIN CrossRef
  5. Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer
    Joana Tato-Costa et al, 2016, Clinical Colorectal Cancer CrossRef
  6. Identification of Commonly Dysregulated Genes in Non-small-cell Lung Cancer by Integrated Analysis of Microarray Data and qRT-PCR Validation
    Zi-Qiang Tian et al, 2015, Lung CrossRef
  7. Stromal contribution to the colorectal cancer transcriptome
    Claudio Isella et al, 2015, Nat Genet CrossRef
  8. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells
    Zhi-Yu Song et al, 2015, Biomedicine & Pharmacotherapy CrossRef
  9. Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer
    Joke Tommelein et al, 2015, Front. Oncol. CrossRef
  10. Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
    James Harper et al, 2014, Semin Cancer Biol CrossRef
  11. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis
    Yida Liao et al, 2013, J Cancer Res Clin Oncol CrossRef
  12. Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).
    Fuming Zi et al, 2015, Mol Med Rep CrossRef
  13. Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
    Yufang Shi et al, 2016, Nat Rev Drug Discov CrossRef
  14. Tumor stroma as targets for cancer therapy.
    Jing Zhang et al, 2013, Pharmacol. Ther. CrossRef
  15. Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer
    Laurine Verset et al, 2015, Radiotherapy and Oncology CrossRef
  16. Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation
    Benjamin Izar et al, 2016, Pigment Cell Melanoma Res. CrossRef
  17. Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy
    Susumu Saigusa et al, 2016, Int J Clin Oncol CrossRef
  18. In vitro models of cancer stem cells and clinical applications
    Sara S. Franco et al, 2016, BMC Cancer CrossRef
  19. Relationships of Alpha-SMA-Positive Fibroblasts and SDF-1-Positive Tumor Cells with Neoangiogenesis in Nasopharyngeal Carcinoma
    Shumin Wang et al, 2014, BioMed Research International CrossRef
  20. Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways
    Sarah K. Baird et al, 2015, Clin Exp Metastasis CrossRef
  21. Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth
    Melanie Mediavilla-Varela et al, 2013, Cancer Biology & Therapy CrossRef
  22. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis.
    Maria L. Wikberg et al, 2013, Tumour Biol. CrossRef
  23. Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression
    Astrid De Boeck et al, 2013, Proteomics CrossRef
  24. Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein
    Roger Yazbeck et al, 2017, Protoplasma CrossRef
  25. Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells
    Xiaoqin Ji et al, 2017, Future Oncology CrossRef
  26. Fibroblasts, an inconspicuous but essential player in colon cancer development and progression
    Naofumi Mukaida et al, 2016, WJG CrossRef
  27. Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts
    Diana Avery et al, 2017, Matrix Biology CrossRef
  28. Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: Angiogenic markers of neoadjuvant chemoradiation
    HAN JO KIM et al, 2014 CrossRef
  29. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways
    Zhi-Yu Song et al, 2018, Cancer Investigation CrossRef
  30. Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma
    Ling Chen et al, 2018, J Clin Pathol CrossRef
  31. Relationship between the expressions of PD-L1 and tumour-associated fibroblasts in gastric cancer
    Linsong Mu et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  32. Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
    Zhanhuai Wang et al, 2019, Cell Commun Signal CrossRef
  33. The Biomechanical Properties of 3d Extracellular Matrices and Embedded Cells Regulate the Invasiveness of Cancer Cells
    Claudia T. Mierke, 2011, Cell Biochem Biophys CrossRef
  34. A TRACER culture invasion assay to probe the impact of cancer associated fibroblasts on head and neck squamous cell carcinoma cell invasiveness
    Teresa Dean et al, 2020, Biomater. Sci. CrossRef
  35. High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes
    Mairene Coto-Llerena et al, 2020, Front. Oncol. CrossRef
  36. Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways.
    Jun Jia et al, 2018, Int J Mol Med CrossRef
  37. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
    Rana Mhaidly et al, 2020, Seminars in Immunology CrossRef
  38. Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies
    Maxim Le Compte et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
  39. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
    Ming Li et al, 2020, acta neuropathol commun CrossRef
  40. Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy
    W. Nathaniel Brennen et al, 2012, Mol Cancer Ther CrossRef
  41. Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers.
    In-Hye Ham et al, 2021, Cancers (Basel) CrossRef
  42. The Role of Fibroblast Activation Protein Ligands in Oncologic PET Imaging
    Katharina Dendl et al, 2021, PET Clinics CrossRef
  43. Tumor microenvironment and radioresistance
    Tatsuya Suwa et al, 2021, Exp Mol Med CrossRef
  44. Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours
    Barbara Kreppel et al, 2021, Nuklearmedizin CrossRef
  45. Extracellular vesicles derived from cancer-associated fibroblast carries miR-224-5p targeting SLC4A4 to promote the proliferation, invasion and migration of colorectal cancer cells
    Yu Zheng et al, 2021 CrossRef
  46. Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple‐negative breast cancers
    Yu‐Wei Hsiao et al, 2022, Clinical & Translational Med CrossRef
  47. Radiotherapy resistance: identifying universal biomarkers for various human cancers
    Irina Larionova et al, 2022, J Cancer Res Clin Oncol CrossRef
  48. Desmoplastic reactions and epithelial-mesenchymal transition proteins in stages II and III colorectal cancer: association with and prognostic value for disease-free survival
    Mai Hashimoto et al, 2022, Virchows Arch CrossRef
  49. Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging
    Katharina Kessel et al, 2022, Ann Nucl Med CrossRef
  50. Fibroblast heterogeneity in solid tumors: from single cell analysis to whole-body imaging
    Agathe Peltier et al, 2022, Seminars in Cancer Biology CrossRef
  51. Research progress on the role of fibroblast activation protein in diagnosis and treatment of cancer
    Zhaoye Wu et al, 2022 CrossRef
  52. Immune-and Metabolism-Associated Molecular Classification of Ovarian Cancer
    Zhenyue Chen et al, 2022, Front. Oncol. CrossRef
  53. High expression of fibroblast‐activating protein is a prognostic marker in non‐small cell lung carcinoma
    Naoki Yanagawa et al, 2022, Thoracic Cancer CrossRef
  54. Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
    Charalampos Fotsitzoudis et al, 2022, Cancers CrossRef
  55. Response Prediction Using18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy
    Xinying Hu et al, 2023, J Nucl Med CrossRef
  56. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Inigo Martinez-Zubiaurre et al, 2023, Cell Commun Signal CrossRef
  57. Prognostic and predictive value of CD163 expression and the CD163 / CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma
    Naoki Yanagawa et al, 2023, Thoracic Cancer CrossRef
  58. The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer
    Zahra Kalaei et al, 2023, Cell Commun Signal CrossRef
  59. Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours
    Michal Zubaľ et al, 2023, Pathology CrossRef
  60. Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review
    Chao Wang et al, 2023, Oncol Res Treat CrossRef
  61. The clinicopathological impact of tumor‐associated macrophages in patients with cutaneous malignant melanoma
    Yoshinari Asai et al, 2023, Journal of Surgical Oncology CrossRef
  62. 18F-FAPI-04 PET/CT parameters predict PD-L1 expression in esophageal squamous cell carcinoma
    Yaqing Zhao et al, 2023, Front. Immunol. CrossRef
  63. Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
    Monika Licaj et al, 2024, Nat Commun CrossRef
  64. Radiation‐induced effects on TGF‐β and PDGF receptor signaling in cancer‐associated fibroblasts
    Nannan Yang et al, 2024, Cancer Reports CrossRef
  65. The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer
    Huajun Cai et al, 2024, Heliyon CrossRef
  66. null
    Katie O’Fee et al, 2024 CrossRef
  67. Brain Metastasis: an insight into novel molecular targets for theranostic approaches
    Liliana Santos et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
  68. Cancer-Associated Fibroblasts in Undifferentiated Nasopharyngeal Carcinoma: A Putative Role for the EBV-Encoded Oncoprotein, LMP1
    Mhairi A. Morris, 2019, Pathogens CrossRef
  69. The Role and Application of Fibroblast Activating Protein
    Xiao-lou Zhang et al, 2024, CMM CrossRef